Chromatin immunoprecipitation (ChIP) assays using monoclonal Kaiso antibodies combined with an Id2-specific PCR confirms that Id2 is a Kaiso target gene in mouse and human E-cadherin deficient breast cancer cells (mILC-1 and MDA-MB231) (Fig. 4B). This evidence concerns the gene ID2 and breast cancer.